|
Re: Book closes.....
|
2
|
Resverlogix Corp.
|
Jun 05, 2019 08:36AM
|
|
Re: Diabetes, dementia, and ABL
|
2
|
Resverlogix Corp.
|
Dec 22, 2019 04:30PM
|
|
Re: Options
|
2
|
Resverlogix Corp.
|
Oct 23, 2019 07:17AM
|
|
Re: Report of exempt distribution
|
2
|
Resverlogix Corp.
|
Jul 01, 2020 06:35PM
|
|
Re: Little confused, any insight would be great
|
2
|
Resverlogix Corp.
|
Mar 05, 2024 05:04AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
2
|
Zenith Epigenetics
|
Feb 25, 2022 07:54AM
|
|
Re: What Now?
|
2
|
Resverlogix Corp.
|
Aug 15, 2024 05:38PM
|
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 10:23AM
|
|
Re: time to get back to sharing information about Bioasis and blood-brain barrier technologies and companies
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 02, 2021 10:07AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
2
|
Resverlogix Corp.
|
May 03, 2021 07:30AM
|
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 15, 2019 09:36AM
|
|
Re: Lots of new options and deferred share units issued on Friday
|
2
|
Resverlogix Corp.
|
May 06, 2020 11:29AM
|
|
Re: Well here we are....
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 10:28AM
|
|
Re: Reminds me of.......
|
2
|
Resverlogix Corp.
|
Jun 25, 2019 10:56AM
|
|
Re: Hope never dies....
|
2
|
Resverlogix Corp.
|
Jun 04, 2021 08:32AM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Feb 25, 2020 01:45PM
|
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 07, 2019 06:50PM
|
|
Re: what are the chances?
|
2
|
Resverlogix Corp.
|
Mar 24, 2022 07:54PM
|
|
Re: Received a response....Third Eye Loan Balance
|
2
|
Resverlogix Corp.
|
Jul 14, 2019 09:14AM
|
|
Re: If BP buys Apabetalone,...
|
2
|
Resverlogix Corp.
|
Nov 05, 2019 02:34PM
|
